Literature DB >> 27626539

Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Gunar Günther1, Christoph Lange1, Sofia Alexandru2, Neus Altet3, Korkut Avsar4, Didi Bang5, Raisa Barbuta6, Graham Bothamley7, Ana Ciobanu2, Valeriu Crudu2, Manfred Danilovits8, Martin Dedicoat9, Raquel Duarte10, Gina Gualano11, Heinke Kunst12, Wiel de Lange13, Vaira Leimane14, Cecile Magis-Escurra15, Anne-Marie McLaughlin16, Inge Muylle17, Veronika Polcová18, Christina Popa19, Rudolf Rumetshofer20, Alena Skrahina21, Varvara Solodovnikova21, Victor Spinu19, Simon Tiberi22, Piret Viiklepp23, Frank van Leth24.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27626539     DOI: 10.1056/NEJMc1603274

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa.

Authors:  Katharine A Yuengling; Nesri Padayatchi; Allison Wolf; Barun Mathema; Tyler Brown; C Robert Horsburgh; Max R OʼDonnell
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-01       Impact factor: 3.731

2.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

3.  More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Authors:  James C M Brust; N Sarita Shah; Neel R Gandhi
Journal:  N Engl J Med       Date:  2016-12-29       Impact factor: 91.245

4.  Tuberculostearic Acid-Containing Phosphatidylinositols as Markers of Bacterial Burden in Tuberculosis.

Authors:  Julius Brandenburg; Jan Heyckendorf; Franziska Marwitz; Nicole Zehethofer; Lara Linnemann; Nicolas Gisch; Hande Karaköse; Maja Reimann; Katharina Kranzer; Barbara Kalsdorf; Patricia Sanchez-Carballo; Michael Weinkauf; Verena Scholz; Sven Malm; Susanne Homolka; Karoline I Gaede; Christian Herzmann; Ulrich E Schaible; Christoph Hölscher; Norbert Reiling; Dominik Schwudke
Journal:  ACS Infect Dis       Date:  2022-06-28       Impact factor: 5.578

Review 5.  Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.

Authors:  Jan Heyckendorf; Sophia B Georghiou; Nicole Frahm; Norbert Heinrich; Irina Kontsevaya; Maja Reimann; David Holtzman; Marjorie Imperial; Daniela M Cirillo; Stephen H Gillespie; Morten Ruhwald
Journal:  Clin Microbiol Rev       Date:  2022-03-21       Impact factor: 50.129

6.  Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study.

Authors:  Ying Zhao; Tamaryn Fox; Kathryn Manning; Annemie Stewart; Nicki Tiffin; Ntokozo Khomo; Joshua Leslie; Andrew Boulle; Vanessa Mudaly; Yulene Kock; Graeme Meintjes; Sean Wasserman
Journal:  Clin Infect Dis       Date:  2019-04-24       Impact factor: 9.079

7.  Immunity to α-Gal: The Opportunity for Malaria and Tuberculosis Control.

Authors:  Alejandro Cabezas-Cruz; José de la Fuente
Journal:  Front Immunol       Date:  2017-12-04       Impact factor: 7.561

8.  A proposed novel framework for monitoring and evaluation of the cascade of HIV-associated TB care at the health facility level.

Authors:  Colleen F Hanrahan; Annelies Van Rie
Journal:  J Int AIDS Soc       Date:  2017-04-20       Impact factor: 5.396

9.  Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence.

Authors:  Christoph Lange; Anna M Mandalakas; Barbara Kalsdorf; Claudia M Denkinger; Martina Sester
Journal:  Pathog Immun       Date:  2016-01-04

10.  DNA hypermethylation during tuberculosis dampens host immune responsiveness.

Authors:  Andrew R DiNardo; Kimal Rajapakshe; Tomoki Nishiguchi; Sandra L Grimm; Godwin Mtetwa; Qiniso Dlamini; Jaqueline Kahari; Sanjana Mahapatra; Alexander Kay; Gugu Maphalala; Emily M Mace; George Makedonas; Jeffrey D Cirillo; Mihai G Netea; Reinout van Crevel; Cristian Coarfa; Anna M Mandalakas
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.